Evaluation of p16/Ki67 dual-stained cytology for detecting cervical precancerous disease

Xuefei GE,Ruiyi ZHANG,Ke YOU,Yanli GUO,Zijian LI,Li GENG
DOI: https://doi.org/10.3969/j.issn.1004-8189.2017.12.011
2017-01-01
Abstract:Objective:To evaluate the clinical application of p16/Ki-67 dual staining in the diagnosis of cervical precancerous disease.Methods:A total of 92 women who were screened at Peking University Third Hospital from January 2017 to May 2017 were recruited in this study.The sensitivity,specificity,positive and negative likelihood ratio,and the area under the ROC curve (AUC)in the detection of ≥CIN2 lesions were compared among the p16 / Ki67dual-staining,TCT and HR-HPV for detecting cervical precancerous disease.The clinical value of p16/Ki-67 dual staining was further evaluated for the identification of ≥ CIN2 lesions in women with positive HR-HPV or elder than 30 years old.Results:For detection of ≥ CIN2 lesions,p16/Ki67 dual-staining had similar sensitivity when compared with TCT and HR-HPV (86.36% vs 84.85% vs 92.42%,P=1.000,P =0.424),and specificity was significant higher than TCT and HR-HPV (76.92 vs 30.77% vs 26.92%,P=0.001,P=0.001),AUC was also higher than TCT and HR-HPV (0.816 vs 0.578 vs 0.597,P =0.001,P<0.001).Similar patterns were observed in the subgroup of women with positive HR-HPV or over than 30 years old.Conclusion:p16 / Ki67dual-staining can improve the specificity of diagnosing ≥CIN2 lesions,and has good clinical application value.
What problem does this paper attempt to address?